RFK Jr. denies being anti-vaccine during intense Senate confirmation
Clinical Trials Arena
Wed, 01/29/25 - 07:29 pm
Robert F Kennedy Jr.
HHS
Senate
vaccines
Donald Trump
Stryker Goes Spineless
Medical Devices and Diagnostics Industry
Wed, 01/29/25 - 07:28 pm
Medtech
Stryker
spinal impants
Teva, despite delivering in 2024, startles investors with subdued 2025 guidance
Fierce Pharma
Wed, 01/29/25 - 07:27 pm
Teva Pharmaceutical
Richard Francis
Pharma CEOs
New Zepbound TV Commercial Inspires ‘Change’
Xtalks
Wed, 01/29/25 - 07:25 pm
Eli Lilly
Zepbound
DTC advertising
television ads
Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Investing.com
Wed, 01/29/25 - 07:22 pm
Inhibikase Therapeutics
Parkinson's Disease
risvodetinib
PAH
Joe Lonsdale’s 8VC seeking $1B for new fund
TechCrunch
Wed, 01/29/25 - 07:21 pm
8VC
venture capital
funding
January 29 2025 - How might the FDA evolve under RFK Jr. and Makary?
Wed, 01/29/25 - 11:51 am
How might the FDA evolve under RFK Jr. and Makary?
BioSpace
Wed, 01/29/25 - 11:48 am
FDA
HHS
regulatory
Robert F Kennedy Jr.
Marty Makary
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Fierce Pharma
Wed, 01/29/25 - 11:46 am
JNJ
bankruptcy
VA
HHS
Trump's administration aims for 'greater transparency' in drug price negotiations
US News and World Report
Wed, 01/29/25 - 11:43 am
Donald Trump
Inflation Reduction Act
drug pricing
transparency
Teva Pharmaceutical Posts Lower Revenue
Investors Business Daily
Wed, 01/29/25 - 11:40 am
Teva Pharmaceutical
earnings
Robert F. Kennedy Jr. testifies at Senate confirmation hearing on his nomination to lead Health and Human Services
CNBC
Wed, 01/29/25 - 11:27 am
Robert F Kennedy Jr.
HHS
Donald Trump
Senate
Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront
Medical Marketing and Media
Wed, 01/29/25 - 11:24 am
Lantheus Holdings
radiopharmaceuticals
M&A
Evergreen Theragnostics
Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June
Fierce Pharma
Wed, 01/29/25 - 11:20 am
Sandoz
Amgen
Celltrion
patents
biosimilars
Prolia
Xgeva
Zentalis lays off 40% of staff to fund registrational trial of WEE1 drug
Fierce Biotech
Wed, 01/29/25 - 11:16 am
Zentalis Pharmaceuticals
layoffs
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Pharma Voice
Wed, 01/29/25 - 11:15 am
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
Troubled 23andMe is exploring a sale of the business
Pharmaphorum
Wed, 01/29/25 - 11:12 am
23andMe
M&A
Medtech
diagnostics
Lawmakers report states shut out of Medicaid payment portals following Trump funding freeze
BioPharma Dive
Tue, 01/28/25 - 09:46 pm
Medicaid
Donald Trump
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Novo Nordisk
FDA
Ozempic
kidney disease
Eli Lilly trial update on kidney drug hurts Tectonic
MSN/Seeking Alpha
Tue, 01/28/25 - 09:39 pm
Eli Lilly
Tectonic Therapeutics
clinical trials
volenrelaxin
TX45

Pages